April 5, 2013 — Toshiba America Medical Systems Inc. has introduced the Aplio 500 and Aplio 300 CV ultrasound systems to help clinicians more accurately and efficiently diagnose cardiovascular disease. Compact and easy-to-use, Aplio 500 CV and Aplio 300 CV deliver exceptional image quality and advanced technologies to improve patient diagnoses and treatment.
Both the Aplio 500 and 300 CV are systems for premium 2-D cardiac exams and feature Toshiba’s 2-D Wall Motion Tracking technology, which provides visualization and quantitative analysis of myocardial wall motion with accuracy and reproducibility. With on-board cardiac quantification measurements in all directions (radial, circumferential, 2-D rotation and longitudinal), the Aplio CV systems are designed to get the most comprehensive information anytime and anywhere in the hospital.
Additional cardiac-specific technologies include tissue enhancement, advanced dynamic flow, lateral gain controls, tissue Doppler, stress echo, Flex-M mode and auto IMT. Both systems are easy to use, with superior ergonomics and a smaller footprint, making them easier to maneuver.
“Aplio 500 and 300 CV provide picture-perfect images with unprecedented resolution, and deliver clinical data faster and more reliably,” said Tomohiro Hasegawa, director, ultrasound business unit, Toshiba. “Combined with 2-D Wall Motion Tracking, physicians can conduct the best bedside cardiac exams and have access to the most comprehensive quantification measurements (strain, strain rates or ejection fraction) on-board the systems and in just three simple clicks.”
For more information: www.medical.toshiba.com
July 19, 2024 
